These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23123941)

  • 21. A role for tau at the synapse in Alzheimer's disease pathogenesis.
    Pooler AM; Noble W; Hanger DP
    Neuropharmacology; 2014 Jan; 76 Pt A():1-8. PubMed ID: 24076336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exenatide and the treatment of patients with Parkinson's disease.
    Aviles-Olmos I; Dickson J; Kefalopoulou Z; Djamshidian A; Ell P; Soderlund T; Whitton P; Wyse R; Isaacs T; Lees A; Limousin P; Foltynie T
    J Clin Invest; 2013 Jun; 123(6):2730-6. PubMed ID: 23728174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".
    Veeraraghavalu K; Zhang C; Miller S; Hefendehl JK; Rajapaksha TW; Ulrich J; Jucker M; Holtzman DM; Tanzi RE; Vassar R; Sisodia SS
    Science; 2013 May; 340(6135):924-f. PubMed ID: 23704555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review: treatment of Alzheimer's disease discovered in repurposed agents.
    Appleby BS; Nacopoulos D; Milano N; Zhong K; Cummings JL
    Dement Geriatr Cogn Disord; 2013; 35(1-2):1-22. PubMed ID: 23307039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain.
    Ulas J; Cotman CW
    Neuroscience; 1997 Aug; 79(4):973-82. PubMed ID: 9219960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug Repositioning for Alzheimer's Disease].
    Ihara M; Saito S
    Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug repositioning and repurposing for Alzheimer disease.
    Ballard C; Aarsland D; Cummings J; O'Brien J; Mills R; Molinuevo JL; Fladby T; Williams G; Doherty P; Corbett A; Sultana J
    Nat Rev Neurol; 2020 Dec; 16(12):661-673. PubMed ID: 32939050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1.
    Al-Zaidy SA; Mendell JR
    Pediatr Neurol; 2019 Nov; 100():3-11. PubMed ID: 31371124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study.
    Tang B; Wang Y; Jiang X; Thambisetty M; Ferrucci L; Johnell K; Hägg S
    Neurology; 2022 Aug; 99(7):e650-e659. PubMed ID: 35654594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic traits and Alzheimer's disease: a Mendelian randomization study.
    Pan Y; Chen W; Yan H; Wang M; Xiang X
    Aging (Albany NY); 2020 Nov; 12(22):22688-22699. PubMed ID: 33202379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MR-Base platform supports systematic causal inference across the human phenome.
    Hemani G; Zheng J; Elsworth B; Wade KH; Haberland V; Baird D; Laurin C; Burgess S; Bowden J; Langdon R; Tan VY; Yarmolinsky J; Shihab HA; Timpson NJ; Evans DM; Relton C; Martin RM; Davey Smith G; Gaunt TR; Haycock PC
    Elife; 2018 May; 7():. PubMed ID: 29846171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease.
    Zhang J; Chen C; Hua S; Liao H; Wang M; Xiong Y; Cao F
    Diabetes Res Clin Pract; 2017 Feb; 124():41-47. PubMed ID: 28088029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic drug target validation using Mendelian randomisation.
    Schmidt AF; Finan C; Gordillo-Marañón M; Asselbergs FW; Freitag DF; Patel RS; Tyl B; Chopade S; Faraway R; Zwierzyna M; Hingorani AD
    Nat Commun; 2020 Jun; 11(1):3255. PubMed ID: 32591531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
    Pulit SL; Stoneman C; Morris AP; Wood AR; Glastonbury CA; Tyrrell J; Yengo L; Ferreira T; Marouli E; Ji Y; Yang J; Jones S; Beaumont R; Croteau-Chonka DC; Winkler TW; ; Hattersley AT; Loos RJF; Hirschhorn JN; Visscher PM; Frayling TM; Yaghootkar H; Lindgren CM
    Hum Mol Genet; 2019 Jan; 28(1):166-174. PubMed ID: 30239722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DrugBank 5.0: a major update to the DrugBank database for 2018.
    Wishart DS; Feunang YD; Guo AC; Lo EJ; Marcu A; Grant JR; Sajed T; Johnson D; Li C; Sayeeda Z; Assempour N; Iynkkaran I; Liu Y; Maciejewski A; Gale N; Wilson A; Chin L; Cummings R; Le D; Pon A; Knox C; Wilson M
    Nucleic Acids Res; 2018 Jan; 46(D1):D1074-D1082. PubMed ID: 29126136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpreting findings from Mendelian randomization using the MR-Egger method.
    Burgess S; Thompson SG
    Eur J Epidemiol; 2017 May; 32(5):377-389. PubMed ID: 28527048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015.
    Mehta D; Jackson R; Paul G; Shi J; Sabbagh M
    Expert Opin Investig Drugs; 2017 Jun; 26(6):735-739. PubMed ID: 28460541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ChEMBL database in 2017.
    Gaulton A; Hersey A; Nowotka M; Bento AP; Chambers J; Mendez D; Mutowo P; Atkinson F; Bellis LJ; Cibrián-Uhalte E; Davies M; Dedman N; Karlsson A; Magariños MP; Overington JP; Papadatos G; Smit I; Leach AR
    Nucleic Acids Res; 2017 Jan; 45(D1):D945-D954. PubMed ID: 27899562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
    Nikpay M; Goel A; Won HH; Hall LM; Willenborg C; Kanoni S; Saleheen D; Kyriakou T; Nelson CP; Hopewell JC; Webb TR; Zeng L; Dehghan A; Alver M; Armasu SM; Auro K; Bjonnes A; Chasman DI; Chen S; Ford I; Franceschini N; Gieger C; Grace C; Gustafsson S; Huang J; Hwang SJ; Kim YK; Kleber ME; Lau KW; Lu X; Lu Y; Lyytikäinen LP; Mihailov E; Morrison AC; Pervjakova N; Qu L; Rose LM; Salfati E; Saxena R; Scholz M; Smith AV; Tikkanen E; Uitterlinden A; Yang X; Zhang W; Zhao W; de Andrade M; de Vries PS; van Zuydam NR; Anand SS; Bertram L; Beutner F; Dedoussis G; Frossard P; Gauguier D; Goodall AH; Gottesman O; Haber M; Han BG; Huang J; Jalilzadeh S; Kessler T; König IR; Lannfelt L; Lieb W; Lind L; Lindgren CM; Lokki ML; Magnusson PK; Mallick NH; Mehra N; Meitinger T; Memon FU; Morris AP; Nieminen MS; Pedersen NL; Peters A; Rallidis LS; Rasheed A; Samuel M; Shah SH; Sinisalo J; Stirrups KE; Trompet S; Wang L; Zaman KS; Ardissino D; Boerwinkle E; Borecki IB; Bottinger EP; Buring JE; Chambers JC; Collins R; Cupples LA; Danesh J; Demuth I; Elosua R; Epstein SE; Esko T; Feitosa MF; Franco OH; Franzosi MG; Granger CB; Gu D; Gudnason V; Hall AS; Hamsten A; Harris TB; Hazen SL; Hengstenberg C; Hofman A; Ingelsson E; Iribarren C; Jukema JW; Karhunen PJ; Kim BJ; Kooner JS; Kullo IJ; Lehtimäki T; Loos RJF; Melander O; Metspalu A; März W; Palmer CN; Perola M; Quertermous T; Rader DJ; Ridker PM; Ripatti S; Roberts R; Salomaa V; Sanghera DK; Schwartz SM; Seedorf U; Stewart AF; Stott DJ; Thiery J; Zalloua PA; O'Donnell CJ; Reilly MP; Assimes TL; Thompson JR; Erdmann J; Clarke R; Watkins H; Kathiresan S; McPherson R; Deloukas P; Schunkert H; Samani NJ; Farrall M
    Nat Genet; 2015 Oct; 47(10):1121-1130. PubMed ID: 26343387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study.
    Qin C; Diaz-Gallo LM; Tang B; Wang Y; Nguyen TD; Harder A; Lu Y; Padyukov L; Askling J; Hägg S
    Eur J Epidemiol; 2023 Jul; 38(7):809-819. PubMed ID: 37052755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.